BBVA
XERS icon

Banco Bilbao Vizcaya Argentaria’s Xeris Biopharma Holdings XERS Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-61,542
Closed -$163K – 764
2020
Q2 		$163K Buy
+61,542
New +$214K 0.01% 728

Other funds holding XERS

SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's XERS Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of Xeris Biopharma Holdings (XERS) in Q3 2020, closing a stake of 61,542 shares — an estimated $163K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in XERS in Q2 2020 and held it in 1 quarter. The position peaked at $163K in Q2 2020. 86 funds tracked by Wall St. Rank hold XERS as of Q3 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Xeris Biopharma Holdings position as of Q3 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 61,542 Xeris Biopharma Holdings shares in Q3 2020, an estimated $163K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Xeris Biopharma Holdings in Q2 2020 and held it in 1 quarter.
  • Banco Bilbao Vizcaya Argentaria's Xeris Biopharma Holdings position peaked at $163K in Q2 2020.
  • 86 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.